| Literature DB >> 28324021 |
Tian Liu1, Akiko Kamiyoshi1, Takayuki Sakurai1, Yuka Ichikawa-Shindo1, Hisaka Kawate1, Lei Yang1, Megumu Tanaka1, Xian Xian1, Akira Imai1, Liuyu Zhai1, Kazutaka Hirabayashi1, Kun Dai1, Keiya Tanimura1, Teng Liu1, Nanqi Cui1, Kyoko Igarashi2, Akihiro Yamauchi2, Takayuki Shindo1.
Abstract
Calcitonin gene-related peptide (CGRP) is a bioactive peptide produced by alternative splicing of the primary transcript of the calcitonin/CGRP gene. CGRP is largely distributed in the cardiovascular and nervous systems, where it acts as a regulatory factor. CGRP is also expressed in organs and tissues involved in metabolic regulation, including white adipose tissue (WAT), where its function is largely unknown. In this study, we examined the effects of endogenous CGRP on metabolic function. When we administered a high-fat diet to CGRP-specific knockout (CGRP-/-) and wild-type (WT) mice for 10 weeks, we observed that food intake did not differ between the two groups, but body weight and visceral fat weight were significantly lower in CGRP-/- mice. Fatty liver changes were less severe in CGRP-/- mice, which also showed lower serum insulin and leptin levels. Glucose tolerance and insulin sensitivity were better in CGRP-/- than WT mice, and expired gas analysis revealed greater oxygen consumption by CGRP-/- mice. Adipocyte hypertrophy was suppressed in CGRP-/- mice, while expression of β-3-adrenergic receptor, hormone-sensitive lipase and adiponectin was enhanced. Isoproterenol-induced glycerol release from WAT was higher in CGRP-/- than WT mice, and CGRP-/- mice showed elevated sympathetic nervous activity. β-receptor-blockade canceled the beneficial effects of CGRP deletion on obesity. These results suggest that, in addition to its actions in the cardiovascular system, endogenous CGRP is a key regulator of metabolism and energy homeostasis in vivo.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28324021 DOI: 10.1210/en.2016-1510
Source DB: PubMed Journal: Endocrinology ISSN: 0013-7227 Impact factor: 4.736